Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.

Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.

Integra LifeSciences (IART) is a stock many investors are watching right now. IART is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value.

Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. IART has a P/S ratio of 1.24. This compares to its industry's average P/S of 2.83.

Finally, our model also underscores that IART has a P/CF ratio of 13.81. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. This company's current P/CF looks solid when compared to its industry's average P/CF of 24.38. Over the past 52 weeks, IART's P/CF has been as high as 17.85 and as low as 8.38, with a median of 13.35.

Value investors will likely look at more than just these metrics, but the above data helps show that Integra LifeSciences is likely undervalued currently. And when considering the strength of its earnings outlook, IART sticks out at as one of the market's strongest value stocks.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Integra LifeSciences Holdings Corporation (IART) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research